• Home
  • NEW DAY MEDICINE
  • 12(50)2022
  • 52 -12 (50) 2022 — Rakhimov B.K., Rasulov Kh.A. — MORPHOFUNCTIONAL CHARACTERISTICS OF THE PISTONE IN AGE AND GENDER ASPECT

52 -12 (50) 2022 — Rakhimov B.K., Rasulov Kh.A. — MORPHOFUNCTIONAL CHARACTERISTICS OF THE PISTONE IN AGE AND GENDER ASPECT

MORPHOFUNCTIONAL CHARACTERISTICS OF THE PISTONE IN AGE AND GENDER ASPECT

Rakhimov B.K., Tashkent Pediatric Medical Institute

Rasulov Kh.A., Tashkent Pediatric Medical Institute

Abdullaeva I.Kh. Tashkent Pediatric Medical Institute

Resume

This article reflects the functional anatomy and structure of the peritoneum, equipped with modern scientific literature, which is focused on data analysis. Based on the study, the cellular composition and topography of the circulatory and lymphatic systems are highlighted. But the age and gender microstructure of the localization of the peritoneum has been little studied. In some pathological processes (adhesive disease, peritonitis and endometriosis), the study of the local reaction of an immunocompetent cell requires a scientific study of the morphofunctional study of the age-related dynamics of mast cells.

Key words: peritoneum, cellular elements, morphology

First page

299

Last page

304

For citation: Rakhimov B.K., Rasulov Kh.A., Abdullaeva I.Kh.MORPHOFUNCTIONAL CHARACTERISTICS OF THE PISTONE IN AGE AND GENDER ASPECT //New Day in Medicine 12(50)2022 299-304 https://clck.ru/3399Bu

LIST OF REFERENCES:

  1. Ahmedov A.G., Mirsharapov O’.M., Sagatov T.A., Rasulov H.A. “Anatomiya”- Том I – II.- Тoshkent. 2018 у. Darslik. “IJOD PRINT”
  2. Rasulov H.A. “Anatomiya”- Xalq tabobati fakulteti uchun darslik Тoshkent. 2021 у. “IJOD PRINT”
  3. Rasulov H.A., Ahmedov A.G. “Anatomiya atlasi”- Том I – II.- III Тoshkent. 2021 у. “IJOD PRINT”
  4. Ахмедов А.Г., Расулов Х.А. -“Атлас анатомии человека” Том I, II.–Тошкент. «Гафур Гулям». – 2015 г.        
  5. Карасёва О.В., Рошаль Л.М., Некрутов А.В. Большой сальник: морфофункциональные особенности и клиническое значение в педиатрии. //Вопр. соврем. педиатрии. 2007; 6 (6): 58–63.
  6. Мнихович М.В., Вернигородский С.В., Буньков К.В. и др. Эпителиально-мезенхимальный переход, трансдифференциация, репрограммирование и метаплазия: современный взгляд на проблему. //Вестн. Нац. Медицинский хирургический центр им. Н.И. Пирогова. 2018; 13 (2): 145– 152.
  7. Златник Е.Ю., Новикова И.А., Непомнящая Е.М. и др. Возможности прогнозирования эффективности лечения сарком мягких тканей на основе особенностей их иммунологического микроокружения. //Казанский мед. ж. 2018; 99 (1): 167–173.
  8. Неродо Г.А., Новикова И.А., Златник Е.Ю. и др. Применение ингарона в комплексе с химиотерапией у больных раком яичников III–IV стадий. //Фундаментал. исслед. 2015; (1–8): 1649–1654.
  9. Титов К.С., Демидов Л.В., Шубина И.Ж. и др. Клиническая эффективность внутриполостной биотерапии у больных с опухолевыми серозитами. //Рос. онкол. ж. 2015; (2): 8–12.
  10. Чердынцева Н.В., Митрофанова И.В., Булдаков М.А. и др. Макрофаги и опухолевая прогрессия: на пути к макрофаг-специфичной терапии. //Бюлл. сибирской мед. 2017; 16 (4): 61–74. DOI: 10.20538/1682-0363-2017-4-61–74.
  11. Bapat S.P., Myoung S.J., Fang S. et al. Depletion of fat-resident Treg cells prevents age-associated insulin resistance. //Nature. 2015; 528 (7580): 137–141. DOI: 10.1038/ nature16151.
  12. Casazza A., Laoui D., Wenes M. et al. Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity. //Cancer Cell. 2013; 24: 695–709. DOI: 10.1016/j.ccr.2013.11.007.
  13. Conroy M.J., Fitzgerald V., Doyle S.L. et al. The microenvironment of visceral adipose tissue and liver alter natural killer cell viability and function. //J. Leukoc. Biol. 2016; 100 (6): 1435–1442. DOI: 10.1189/jlb.5AB1115-493RR.
  14. Conroy M.J., Maher S.G., Melo A.M. et al. Identifying a novel role for Fractalkine (CX3CL1) in memory CD8+ T cell accumulation in the omentum of obesity-associated cancer patients. //Front. Immunol. 2018; 9:1867. DOI: 10.3389/fimmu.2018.01867.
  15. Fessler J., Matson V., Gajewski T.F. Exploring the emerging role of themicrobiome in cancer immunotherapy. //J. Immun. Ther. Cancer. 2019; 7: 108–123. DOI: 10.1186/ s40425-019-0574-4.
  16. Hang Ch., Xin H., Zhang W. et al. CD5 binds to interleukin-6 and induces a feed-forward loop with the transcription factor STAT3 in B cells to promote cancer. //Immunity. 2016; 44: 913–923. DOI: 10.1016/j.immuni. 2016.04.003.
  17. Horikawa N., Abiko K., Matsumura N. et al. Expression of vascular endothelial growth factor in ovarian cancer inhibits tumor immunity through the accumulation of myeloid-derived suppressor cells. //Clin. Cancer Res. 2017; 23 (2): 587–599. DOI: 10.1158/1078-0432.CCR16-0387.
  18. Jackson-Jones L.H., Duncan S.M., Magalhaes M.S. et al. Fat-associated lymphoid clusters control local IgM secretion during pleural infection and lung inflamemation. //Nat. Commun. 2016; 7: 12 651. DOI: 10.1038/ncomms12651.
  19. Liu J., Geng X., Li Y. Milky spots: omental functional units and hotbeds for peritoneal cancer metastasis. //Tumor Boil. 2016; 37: 5715–5726. DOI: 10.1007/s13277-016- 4887-3.
  20. Meza-Perez S., Randall T.D. Immunological functions of the omentum. //Trends Immunol. 2017; 38 (7): 526– 536. DOI: 10.1016/j.it.2017.03.002.

file

download